GE HealthCare Technologies Inc. (GEHC) vs Moderna, Inc. (MRNA)

GEHC leads on 7 of 9 compared metrics.

A side-by-side comparison of GE HealthCare Technologies Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 29, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare

Total return — GEHC vs MRNA

growth of $100 · last 4y
GEHC +9.6%MRNA -67.5%GEHC compounded faster
050100150Start $1002023202420252026$110$32
GEHC MRNA

GEHC vs MRNA: by the numbers

  • GEHC is the larger company ($29.91B vs $26.69B market cap).
  • GEHC is profitable (7.54% net margin) while MRNA runs a net loss (-143.55%).
  • GEHC grew revenue faster over the past five years (3.74% vs -2.60% CAGR).
  • GEHC pays a dividend (0.21% yield) while MRNA does not currently pay one.

Which is better, GEHC or MRNA?

Metric tally: GEHC 7 · MRNA 2

It depends on what you're optimizing for:

GrowthGEHC(faster 5Y revenue CAGR)
QualityGEHC(higher ROIC)

Metrics side by side

Valuation

MetricGEHCMRNA
P/E ratio20.11
Forward P/E12.17
P/S ratio1.5111.94
P/B ratio2.823.59
PEG ratio4.14
EV / EBITDA11.01
FCF yield5.06%

Profitability

MetricGEHCMRNA
Gross margin42.55%55.35%
Operating margin12.46%-153.35%
Net margin7.54%-143.55%
ROE14.11%-43.12%
ROIC8.84%-29.70%

Dividends

MetricGEHCMRNA
Dividend yield0.21%
Payout ratio3.07%

Growth (annualized)

MetricGEHCMRNA
Revenue CAGR (5Y)3.74%-2.60%
EPS CAGR (5Y)0.67%
FCF CAGR (5Y)1.07%126.92%
Total return CAGR (5Y)-21.09%

Frequently asked

Which is better, GEHC or MRNA?
It depends on your goal. growth: GEHC (faster 5Y revenue CAGR); quality: GEHC (higher ROIC). Across all compared metrics, GEHC leads 7 to 2.
Which has grown faster, GEHC or MRNA?
Over the past five years, GEHC grew revenue faster — GEHC at a 3.74% CAGR versus MRNA at -2.60%.
Does GEHC or MRNA pay a bigger dividend?
GEHC pays a dividend (0.21% yield) while MRNA does not currently pay one.
Is GEHC or MRNA more profitable?
GEHC runs the higher net margin — GEHC at 7.54% versus MRNA at -143.55%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 29, 2026.